206 related articles for article (PubMed ID: 29985971)
1. Computational analysis of kinase inhibitor selectivity using structural knowledge.
Lo YC; Liu T; Morrissey KM; Kakiuchi-Kiyota S; Johnson AR; Broccatelli F; Zhong Y; Joshi A; Altman RB
Bioinformatics; 2019 Jan; 35(2):235-242. PubMed ID: 29985971
[TBL] [Abstract][Full Text] [Related]
2. Structure-guided selection of specificity determining positions in the human Kinome.
Moll M; Finn PW; Kavraki LE
BMC Genomics; 2016 Aug; 17 Suppl 4(Suppl 4):431. PubMed ID: 27556159
[TBL] [Abstract][Full Text] [Related]
3. Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis.
Huang D; Zhou T; Lafleur K; Nevado C; Caflisch A
Bioinformatics; 2010 Jan; 26(2):198-204. PubMed ID: 19942586
[TBL] [Abstract][Full Text] [Related]
4. Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804.
Xing L; Shieh HS; Selness SR; Devraj RV; Walker JK; Devadas B; Hope HR; Compton RP; Schindler JF; Hirsch JL; Benson AG; Kurumbail RG; Stegeman RA; Williams JM; Broadus RM; Walden Z; Monahan JB
Biochemistry; 2009 Jul; 48(27):6402-11. PubMed ID: 19496616
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Anastassiadis T; Deacon SW; Devarajan K; Ma H; Peterson JR
Nat Biotechnol; 2011 Oct; 29(11):1039-45. PubMed ID: 22037377
[TBL] [Abstract][Full Text] [Related]
6. Perspective on computational and structural aspects of kinase discovery from IPK2014.
Martin E; Knapp S; Engh RA; Moebitz H; Varin T; Roux B; Meiler J; Berdini V; Baumann A; Vieth M
Biochim Biophys Acta; 2015 Oct; 1854(10 Pt B):1595-604. PubMed ID: 25861861
[TBL] [Abstract][Full Text] [Related]
7. Kinase-kernel models: accurate in silico screening of 4 million compounds across the entire human kinome.
Martin E; Mukherjee P
J Chem Inf Model; 2012 Jan; 52(1):156-70. PubMed ID: 22133092
[TBL] [Abstract][Full Text] [Related]
8. Computational proteomics of biomolecular interactions in the sequence and structure space of the tyrosine kinome: deciphering the molecular basis of the kinase inhibitors selectivity.
Verkhivker GM
Proteins; 2007 Mar; 66(4):912-29. PubMed ID: 17173284
[TBL] [Abstract][Full Text] [Related]
9. The small-molecule inhibitor selectivity between IKKα and IKKβ kinases in NF-κB signaling pathway.
Tian F; Zhou P; Kang W; Luo L; Fan X; Yan J; Liang H
J Recept Signal Transduct Res; 2015; 35(4):307-18. PubMed ID: 25386663
[TBL] [Abstract][Full Text] [Related]
10. Strategy toward Kinase-Selective Drug Discovery.
Zhang M; Liu Y; Jang H; Nussinov R
J Chem Theory Comput; 2023 Mar; 19(5):1615-1628. PubMed ID: 36815703
[TBL] [Abstract][Full Text] [Related]
11. Pocketome of human kinases: prioritizing the ATP binding sites of (yet) untapped protein kinases for drug discovery.
Volkamer A; Eid S; Turk S; Jaeger S; Rippmann F; Fulle S
J Chem Inf Model; 2015 Mar; 55(3):538-49. PubMed ID: 25557645
[TBL] [Abstract][Full Text] [Related]
12. Selective JAK3 Inhibitors with a Covalent Reversible Binding Mode Targeting a New Induced Fit Binding Pocket.
Forster M; Chaikuad A; Bauer SM; Holstein J; Robers MB; Corona CR; Gehringer M; Pfaffenrot E; Ghoreschi K; Knapp S; Laufer SA
Cell Chem Biol; 2016 Nov; 23(11):1335-1340. PubMed ID: 27840070
[TBL] [Abstract][Full Text] [Related]
13. What Makes a Kinase Promiscuous for Inhibitors?
Hanson SM; Georghiou G; Thakur MK; Miller WT; Rest JS; Chodera JD; Seeliger MA
Cell Chem Biol; 2019 Mar; 26(3):390-399.e5. PubMed ID: 30612951
[TBL] [Abstract][Full Text] [Related]
14. Development of Kinase-Centric Drugs: A Computational Perspective.
Pratap Reddy Gajulapalli V
ChemMedChem; 2023 Oct; 18(19):e202200693. PubMed ID: 37442809
[TBL] [Abstract][Full Text] [Related]
15. Multimodal multi-task deep neural network framework for kinase-target prediction.
Hua Y; Luo L; Qiu H; Huang D; Zhao Y; Liu H; Lu T; Chen Y; Zhang Y; Jiang Y
Mol Divers; 2023 Dec; 27(6):2491-2503. PubMed ID: 36369613
[TBL] [Abstract][Full Text] [Related]
16. Quantitative Structure-Activity Relationship Modeling of Kinase Selectivity Profiles.
Kothiwale S; Borza C; Pozzi A; Meiler J
Molecules; 2017 Sep; 22(9):. PubMed ID: 28925954
[TBL] [Abstract][Full Text] [Related]
17. Development and implementation of three mitogen-activated protein kinase (MAPK) signaling pathway imaging assays to provide MAPK module selectivity profiling for kinase inhibitors: MK2-EGFP translocation, c-Jun, and ERK activation.
Nickischer D; Laethem C; Trask OJ; Williams RG; Kandasamy R; Johnston PA; Johnston PA
Methods Enzymol; 2006; 414():389-418. PubMed ID: 17110204
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive Data-Driven Assessment of Non-Kinase Targets of Inhibitors of the Human Kinome.
Mobasher M; Vogt M; Xerxa E; Bajorath J
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540679
[TBL] [Abstract][Full Text] [Related]
19. DFGmodel: predicting protein kinase structures in inactive states for structure-based discovery of type-II inhibitors.
Ung PM; Schlessinger A
ACS Chem Biol; 2015 Jan; 10(1):269-78. PubMed ID: 25420233
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into AGC kinase inhibition.
Breitenlechner C; Gassel M; Engh R; Bossemeyer D
Oncol Res; 2004; 14(6):267-78. PubMed ID: 15206489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
